A. We randomly selected 20 mutually exclusive groups of protein complexes that contained exactly five subunits; we mapped the corresponding gene pairs to SINaTRA scores, and plotte... by Alexandra Jacunski (5665486)

“…Although proteins in the same complex are always enriched for higher SINaTRA score, as complex size increases, complex membership becomes less indicative of two genes being SL. C. We compared the fraction of gene pairs with products in the same vs. different complexes for three SINaTRA cutoffs (0.95, 0.80, 0.50) as well as for all gene pairs. …”

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. by Michael Gulledge (20577135)

Mean values (± standard deviation) of liver profile parameters before and after CWI. by Aneta Teległów (9570190)

Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

“…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R¹ = R²) have only an S_A phase, while for unsymmetrical alkoxy substitution a monotropic S_E phase occurs and the melting temperature decreases with no loss in mesophase stability. …”

Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

“…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R¹ = R²) have only an S_A phase, while for unsymmetrical alkoxy substitution a monotropic S_E phase occurs and the melting temperature decreases with no loss in mesophase stability. …”

Mean countermovement jump height without (CON, white) and with ammonia inhalants (AI, black). by Jan Maleček (17396660)

Subjects:

Fig 3 - by Jan Maleček (17396660)

Subjects:

Fig 7 - by Jan Maleček (17396660)

Subjects:

Fig 4 - by Jan Maleček (17396660)

Subjects:

Mean heart rate percentage difference (between CON and AI at each 15-second time span). by Jan Maleček (17396660)

Subjects:

Overview of the study protocol. by Jan Maleček (17396660)

Subjects:

Descriptive statistics of all results at baseline after a full night of sleep (0 h), after 12 (-12 h), 24 (-24 h) and 36 (-36 h) hours of total sleep deprivation followed by 8 (+8... by Jan Maleček (17396660)

Subjects:

Flow diagram for crossover trial of each testing period either with ammonia inhalants or without (control group). by Jan Maleček (17396660)

Subjects:

The authorship rating was a 6-point rating scale of the degree of authorship, ranging from 1 “I could not manipulate the window at all” to 6 “I completely manipulated the window”.... by Junhui Kim (18575083)

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

“…Survival and six major types of side effects were assessed based on data in the articles and reported using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Heterogeneity was assessed using Higgins and Thompson’s I² statistics.…”

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…Survival and six major types of side effects were assessed based on data in the articles and reported using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Heterogeneity was assessed using Higgins and Thompson’s I² statistics.…”

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…Survival and six major types of side effects were assessed based on data in the articles and reported using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Heterogeneity was assessed using Higgins and Thompson’s I² statistics.…”

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…(<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”